MedTrace Logo

Jikei Optimal Insulin Therapy in Type 2 Diabetes

NCT00348231 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2006-09-01

No results posted yet for this study

Summary

The purpose of this study is to compare whether there is the difference in the effect of insulin therapy by the number of times of insulin injection.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

dual-action insulin analog

Sponsors & Collaborators

  • Novo Nordisk A/S

    collaborator INDUSTRY

  • Jikei University School of Medicine

    lead OTHER

Principal Investigators

  • Yumi Miyashita, MD · The Jikei University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Completion
2006-08-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00348231 on ClinicalTrials.gov